Synopsys Aktie
WKN: 883703 / ISIN: US8716071076
05.03.2025 19:10:27
|
Synopsys Reacts To U.K. CMA's Phase 1 Decision On Ansys Deal
(RTTNews) - Synopsys, Inc. (SNPS) issued a statement on Wednesday regarding the U.K. Competition and Markets Authority's (CMA) decision on its proposed acquisition of Ansys. The company expressed satisfaction with the CMA's Phase 1 approval, which is subject to previously announced divestitures. Synopsys continues to pursue regulatory approvals in other regions and anticipates completing the transaction in the first half of 2025.
During the company's recent earnings call, President and CEO Sassine Ghazi emphasized strong customer support for the acquisition. He highlighted that the merger would enable the development of AI-powered design solutions integrating electronics and physics, equipping R&D teams with advanced tools to drive innovation.
SNPS is currently trading at $443.5 0.44% lower on the Nasdaq Global Select Market.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Synopsys Inc.mehr Nachrichten
16:04 |
NASDAQ Composite Index-Papier Synopsys-Aktie: So viel Gewinn hätte eine Investition in Synopsys von vor 3 Jahren abgeworfen (finanzen.at) | |
15.07.25 |
Börse New York in Grün: NASDAQ Composite letztendlich mit Zuschlägen (finanzen.at) | |
15.07.25 |
NASDAQ 100 aktuell: NASDAQ 100 zeigt sich letztendlich fester (finanzen.at) | |
14.07.25 |
China approves $35bn Synopsys chip software deal after US eases export curbs (Financial Times) | |
14.07.25 |
China approves $35bn Synopsys chip software deal after US eases export curbs (Financial Times) | |
10.07.25 |
NASDAQ-Handel NASDAQ 100 fällt letztendlich (finanzen.at) | |
09.07.25 |
NASDAQ Composite Index-Wert Synopsys-Aktie: So viel Verlust hätte ein Investment in Synopsys von vor einem Jahr eingebracht (finanzen.at) | |
03.07.25 |
NASDAQ-Handel: NASDAQ 100 verbucht zum Handelsende Gewinne (finanzen.at) |
Analysen zu Synopsys Inc.mehr Analysen
Aktien in diesem Artikel
Synopsys Inc. | 487,40 | 3,16% |
|